FFP104

Fast Forward Pharmaceuticals · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	FFP104
Sponsor	Fast Forward Pharmaceuticals
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Pilot Study of FFP104 Dose Escalation in PBC Subjects (PHASE1, PHASE2)
A Pilot Study of FFP104 in Subjects With Crohn's Disease (PHASE1, PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

FFP104 CI brief — competitive landscape report
FFP104 updates RSS · CI watch RSS
Fast Forward Pharmaceuticals portfolio CI